Skip to main content
. 2024 Nov 20;15:1461571. doi: 10.3389/fphar.2024.1461571

FIGURE 3.

FIGURE 3

Price simulation of the United States (A) Patients with ITT, (B) Patients with TAP ≥ 5%.